Świerczewska, M.; Sterzyńska, K.; Wojtowicz, K.; Kaźmierczak, D.; Iżycki, D.; Nowicki, M.; Zabel, M.; Januchowski, R.
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations. Int. J. Mol. Sci. 2019, 20, 2053.
https://doi.org/10.3390/ijms20082053
AMA Style
Świerczewska M, Sterzyńska K, Wojtowicz K, Kaźmierczak D, Iżycki D, Nowicki M, Zabel M, Januchowski R.
PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations. International Journal of Molecular Sciences. 2019; 20(8):2053.
https://doi.org/10.3390/ijms20082053
Chicago/Turabian Style
Świerczewska, Monika, Karolina Sterzyńska, Karolina Wojtowicz, Dominika Kaźmierczak, Dariusz Iżycki, Michał Nowicki, Maciej Zabel, and Radosław Januchowski.
2019. "PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations" International Journal of Molecular Sciences 20, no. 8: 2053.
https://doi.org/10.3390/ijms20082053
APA Style
Świerczewska, M., Sterzyńska, K., Wojtowicz, K., Kaźmierczak, D., Iżycki, D., Nowicki, M., Zabel, M., & Januchowski, R.
(2019). PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations. International Journal of Molecular Sciences, 20(8), 2053.
https://doi.org/10.3390/ijms20082053